Bharat Parenterals Limited

BPLPHARMA6

INE365Y01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:56 16/07/2024 BST			5-day change	1st Jan Change
1,487 ^INR	-2.03%		-4.17%	+83.61%

07-04	Bharat Parenterals Limited Declares Dividend for the Financial Year 2023-24	CI
06-24	Bharat Parenterals Limited agreed to acquire an unknown majority stake in Varenyam Biolifesciences Private Limited for INR 22.56 million.	CI

Bharat Parenterals Limited Declares Dividend for the Financial Year 2023-24

July 04, 2024 at 05:48 am

Bharat Parenterals Limited declared final dividend of INR 1 (10%) per Ordinary (equity) Share of Face value of INR 10/- each for the Financial Year 2023-24.

Latest news about Bharat Parenterals Limited

Bharat Parenterals Limited Declares Dividend for the Financial Year 2023-24	07-04	CI
Bharat Parenterals Limited agreed to acquire an unknown majority stake in Varenyam Biolifesciences Private Limited for INR 22.56 million.	06-23	CI
Bharat Parenterals to Raise Stake in Subsidiary Innoxel Lifesciences	06-06	MT
Bharat Parenterals Limited agreed to acquire an additional 4.89% stake in Innoxel Lifesciences Private Limited for approximately INR 650.	06-04	CI
Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-22	CI
Bharat Parenterals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-22	CI
Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Bharat Parenterals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Bharat Parenterals Limited Appoints Krutika Padmakar Bhattbhatt as Company Secretary and Compliance Officer	02/10/23	CI
Bharat Parenterals Limited Announces Resignation of Shyam Singh Rajpurohit as Company Secretary and Compliance Officer	02/10/23	CI
Bharat Parenterals Limited Declares Dividend for the Financial Year 2022 to 2023	30/09/23	CI
Bharat Parenterals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09/08/23	CI
Bharat Parenterals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	07/06/23	CI
Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	20/05/23	CI
Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23	CI
Bharat Parenterals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	12/11/22	CI
Bharat Parenterals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	10/08/22	CI
Bharat Parenterals Forms New Unit	17/06/22	MT
Bharat Parenterals Limited Reports Earnings Results for the Full Year Ended March 31, 2022	28/05/22	CI
Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	28/05/22	CI
Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	09/02/22	CI
Bharat Parenterals Limited Announces Change in Registered Office Address	04/01/22	CI
Bharat Parenterals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	30/10/21	CI
Bharat Parenterals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	11/08/21	CI
Bharat Parenterals' : Consolidated Profit Plunges in Fiscal Q4	07/06/21	MT

Chart Bharat Parenterals Limited

Duration

Period

More charts

Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies.

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BHARAT PARENTERALS LIMITED	+83.61%	116M
ELI LILLY AND COMPANY	+61.53%	848B
NOVO NORDISK A/S	+33.88%	627B
JOHNSON & JOHNSON	-3.66%	363B
MERCK & CO., INC.	+15.06%	318B
ABBVIE INC.	+9.18%	299B
ROCHE HOLDING AG	+12.19%	234B
NOVARTIS AG	+16.14%	225B
AMGEN INC.	+15.67%	179B
PFIZER, INC.	+2.47%	167B